Cadence Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Cadence Capital Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-31,066	Closed	-$820K	–	353
2020 Q2	$820K	Sell	31,066 -22,773	-42%	-$595K	0.12%	254
2020 Q1	$1.34M	Sell	53,839 -2,802	-5%	-$86.5K	0.23%	124
2019 Q4	$2.04M	Buy	+56,641	New	+$1.95M	0.22%	132
2018 Q4	–	Sell	-83,497	Closed	-$3.23M	–	546
2018 Q3	$3.23M	Buy	83,497 +13,984	+20%	+$504K	0.18%	141
2018 Q2	$2.33M	Buy	69,513 +21,603	+45%	+$769K	0.14%	195
2018 Q1	$1.74M	Buy	+47,910	New	+$1.66M	0.11%	239
2016 Q1	–	Sell	-36,050	Closed	-$622K	–	655
2015 Q4	$622K	Sell	36,050 -2,527	-7%	-$36.6K	0.04%	435
2015 Q3	$470K	Buy	+38,577	New	+$495K	0.03%	462

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

SCA

Summit Creek Advisors Minneapolis, Minnesota $487M AUM 11.23% 1-Year Est. Return

Cadence Capital Management's LMAT Position: Q3 2020 in Review

Cadence Capital Management sold out of LeMaitre Vascular (LMAT) in Q3 2020, closing a stake of 31,066 shares — an estimated $820K sold.

Cadence Capital Management first reported a position in LMAT in Q3 2015 and held it in 8 quarters. The position peaked at $3.23M in Q3 2018. 141 funds tracked by Wall St. Rank hold LMAT as of Q3 2020.

Cadence Capital Management reported no remaining LeMaitre Vascular position as of Q3 2020 after selling out during the quarter.
Cadence Capital Management sold 31,066 LeMaitre Vascular shares in Q3 2020, an estimated $820K.
Cadence Capital Management first reported a position in LeMaitre Vascular in Q3 2015 and held it in 8 quarters.
Cadence Capital Management's LeMaitre Vascular position peaked at $3.23M in Q3 2018.
141 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2020.

Based on Cadence Capital Management's 13F filing for Q3 2020, filed 16 Oct 2020.